Patent details
300622
Product Name:
Nepafenac
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300622
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP0999825
Status:
Renounced Art. 14 (b) of the EC Regulations
Application number:
300622
Procedural language:
Dutch
First Applicant Residence Country:
Marketing Authorization
Marketing Authorization Number:
EU/1/07/433/002
Marketing Authorization Type:
EEA
Marketing Authorization Date:
03/05/2013
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
04/11/2013
First Marketing Authorization date:
03/05/2013
Grant date:
30/01/2014
Activation date:
17/07/2018
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
30/01/2014
NullificationDate:
Registration date:
04/11/2013
SPC/SPC Extension Expiration Date:
16/07/2023
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
14/01/2020
Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)
Historical Applicant/holder
From:
14/01/2020
To:
14/01/2020
Name:
ALCON VISION, LLC
Address:
6201 South Freeway, 76134, Fort Worth, TX, United States of America (US)
From:
04/11/2013
To:
14/01/2020
Name:
ALCON LABORATORIES, INC
Address:
6201 South Freeway Mail Code Q-148, 76134-2099, Fort Worth, Texas, United States of America (US)
Agent
Name:
ir. J.C. Volmer c.s.
From:
04/11/2013
Address:
Exter Polak & Charlouis B.V.
Postbus 3241, 2280 GE, Rijswijk, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
50/20
Publication date:
09/12/2020
Description:
Lapse or annulment
2
Bulletin Heading:
MED
Journal edition number:
50/20
Publication date:
09/12/2020
Description:
Other communications
3
Bulletin Heading:
CO
Journal edition number:
04/20
Publication date:
22/01/2020
Description:
Changes in the Netherlands Patent Register
4
Bulletin Heading:
CO
Journal edition number:
04/20
Publication date:
22/01/2020
Description:
Changes in the Netherlands Patent Register
5
Bulletin Heading:
SPC
Journal edition number:
30/18
Publication date:
18/07/2018
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
6
Bulletin Heading:
SPC
Journal edition number:
2014/06
Publication date:
06/02/2014
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
7
Bulletin Heading:
SPC
Journal edition number:
2013/46
Publication date:
13/11/2013
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Surrender
Change Kind/ Decision Type:
Total - Renunciation
Deed Number:
RC202002245A
Date Registered:
12/11/2020
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. J.C. Volmer c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Change of owner(s)
Change Kind/ Decision Type:
Merge
Deed Number:
RC202000095A
Date Registered:
14/01/2020
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
Name:
ALCON VISION, LLC
Address:
6201 South Freeway, 76134, Fort Worth, TX, United States of America (US)
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Change of owner(s)
Change Kind/ Decision Type:
Assignment
Deed Number:
RC202000095B
Date Registered:
14/01/2020
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Annual Fee
Annual Fee(s) Due Date:
31/07/2021
Annual Fee Number:
24
Annual Fee Amount:
2200 Euro
Last Annual Payment Date:
22/06/2020
Last Annual Fee Paid Number:
23
Last Annual Fee Paid Amount:
2000 Euro
Payer:
Arnold & Siedsma BV
Filing date
Document type
Document Description
Number of pages
File Type
17/09/2020
SPC Documents
SPC Documents
1
PDF
/2/2/6/0/0/0400300622/docs/300622_5_supplprotectioncertificate20200917025233616.pdf
30/01/2014
SPC Documents
Certificate SPC
1
PDF
/2/2/6/0/0/0400300622/docs/300622_4_supplprotectioncertificate20210223030657638.pdf
30/01/2014
Outgoing Correspondence
Outgoing Letter
1
PDF
/2/2/6/0/0/0400300622/docs/300622_6_outgoingcorrespondence20140130.pdf
04/11/2013
SPC Documents
Marketing Authorization SPC
3
PDF
/2/2/6/0/0/0400300622/docs/300622_0_supplprotectioncertificate20210223030051955.pdf
04/11/2013
Application Form
First filed application form
2
PDF
/2/2/6/0/0/0400300622/docs/300622_1_applicationform20131104.pdf
04/11/2013
SPC Documents
Accompanying letter SPC
1
PDF
/2/2/6/0/0/0400300622/docs/300622_2_supplprotectioncertificate20210223025727393.pdf
04/11/2013
SPC Documents
Summary of the characteristics of the product
9
PDF
/2/2/6/0/0/0400300622/docs/300622_3_supplprotectioncertificate20210223025541542.pdf